异体造血干细胞移植后 B 细胞重建的动态变化:真实世界研究。

IF 9 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Journal of Internal Medicine Pub Date : 2024-03-04 DOI:10.1111/joim.13776
Guangyu Zhou, Qian Zhan, Lingle Huang, Xi Dou, Jin Cui, Lin Xiang, Yuhong Qi, Sicen Wu, Lin Liu, Qing Xiao, Jianbin Chen, Xiaoqiong Tang, Hongbin Zhang, Xin Wang, Xiaohua Luo, Guosheng Ren, Zesong Yang, Lanxiang Liu, Xinyu Yan, Qin Luo, Caixia Pei, Yulian Dai, Yu Zhu, Hao Zhou, Guilin Ren, Li Wang
{"title":"异体造血干细胞移植后 B 细胞重建的动态变化:真实世界研究。","authors":"Guangyu Zhou,&nbsp;Qian Zhan,&nbsp;Lingle Huang,&nbsp;Xi Dou,&nbsp;Jin Cui,&nbsp;Lin Xiang,&nbsp;Yuhong Qi,&nbsp;Sicen Wu,&nbsp;Lin Liu,&nbsp;Qing Xiao,&nbsp;Jianbin Chen,&nbsp;Xiaoqiong Tang,&nbsp;Hongbin Zhang,&nbsp;Xin Wang,&nbsp;Xiaohua Luo,&nbsp;Guosheng Ren,&nbsp;Zesong Yang,&nbsp;Lanxiang Liu,&nbsp;Xinyu Yan,&nbsp;Qin Luo,&nbsp;Caixia Pei,&nbsp;Yulian Dai,&nbsp;Yu Zhu,&nbsp;Hao Zhou,&nbsp;Guilin Ren,&nbsp;Li Wang","doi":"10.1111/joim.13776","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>The immune reconstitution after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is crucial for preventing infections and relapse and enhancing graft-versus-tumor effects. B cells play an important role in humoral immunity and immune regulation, but their reconstitution after allo-HSCT has not been well studied.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>In this study, we analyzed the dynamics of B cells in 252 patients who underwent allo-HSCT for 2 years and assessed the impact of factors on B-cell reconstitution and their correlations with survival outcomes, as well as the development stages of B cells in the bone marrow and the subsets in the peripheral blood.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>We found that the B-cell reconstitution in the bone marrow was consistent with the peripheral blood (<i>p</i> = 0.232). B-cell reconstitution was delayed by the male gender, age &gt;50, older donor age, the occurrence of chronic and acute graft-versus-host disease, and the infections of fungi and cytomegalovirus. The survival analysis revealed that patients with lower B cells had higher risks of death and relapse. More importantly, we used propensity score matching to obtain the conclusion that post-1-year B-cell reconstitution is better in females. Meanwhile, using mediation analysis, we proposed the age-B cells-survival axis and found that B-cell reconstitution at month 12 posttransplant mediated the effect of age on patient survival (<i>p</i> = 0.013). We also found that younger patients showed more immature B cells in the bone marrow after transplantation (<i>p</i> = 0.037).</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Our findings provide valuable insights for optimizing the management of B-cell reconstitution and improving the efficacy and safety of allo-HSCT.</p>\n </section>\n </div>","PeriodicalId":196,"journal":{"name":"Journal of Internal Medicine","volume":"295 5","pages":"634-650"},"PeriodicalIF":9.0000,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/joim.13776","citationCount":"0","resultStr":"{\"title\":\"The dynamics of B-cell reconstitution post allogeneic hematopoietic stem cell transplantation: A real-world study\",\"authors\":\"Guangyu Zhou,&nbsp;Qian Zhan,&nbsp;Lingle Huang,&nbsp;Xi Dou,&nbsp;Jin Cui,&nbsp;Lin Xiang,&nbsp;Yuhong Qi,&nbsp;Sicen Wu,&nbsp;Lin Liu,&nbsp;Qing Xiao,&nbsp;Jianbin Chen,&nbsp;Xiaoqiong Tang,&nbsp;Hongbin Zhang,&nbsp;Xin Wang,&nbsp;Xiaohua Luo,&nbsp;Guosheng Ren,&nbsp;Zesong Yang,&nbsp;Lanxiang Liu,&nbsp;Xinyu Yan,&nbsp;Qin Luo,&nbsp;Caixia Pei,&nbsp;Yulian Dai,&nbsp;Yu Zhu,&nbsp;Hao Zhou,&nbsp;Guilin Ren,&nbsp;Li Wang\",\"doi\":\"10.1111/joim.13776\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>The immune reconstitution after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is crucial for preventing infections and relapse and enhancing graft-versus-tumor effects. B cells play an important role in humoral immunity and immune regulation, but their reconstitution after allo-HSCT has not been well studied.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>In this study, we analyzed the dynamics of B cells in 252 patients who underwent allo-HSCT for 2 years and assessed the impact of factors on B-cell reconstitution and their correlations with survival outcomes, as well as the development stages of B cells in the bone marrow and the subsets in the peripheral blood.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>We found that the B-cell reconstitution in the bone marrow was consistent with the peripheral blood (<i>p</i> = 0.232). B-cell reconstitution was delayed by the male gender, age &gt;50, older donor age, the occurrence of chronic and acute graft-versus-host disease, and the infections of fungi and cytomegalovirus. The survival analysis revealed that patients with lower B cells had higher risks of death and relapse. More importantly, we used propensity score matching to obtain the conclusion that post-1-year B-cell reconstitution is better in females. Meanwhile, using mediation analysis, we proposed the age-B cells-survival axis and found that B-cell reconstitution at month 12 posttransplant mediated the effect of age on patient survival (<i>p</i> = 0.013). We also found that younger patients showed more immature B cells in the bone marrow after transplantation (<i>p</i> = 0.037).</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>Our findings provide valuable insights for optimizing the management of B-cell reconstitution and improving the efficacy and safety of allo-HSCT.</p>\\n </section>\\n </div>\",\"PeriodicalId\":196,\"journal\":{\"name\":\"Journal of Internal Medicine\",\"volume\":\"295 5\",\"pages\":\"634-650\"},\"PeriodicalIF\":9.0000,\"publicationDate\":\"2024-03-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/joim.13776\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Internal Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/joim.13776\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Internal Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/joim.13776","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

摘要

背景:异基因造血干细胞移植(allo-HSCT)后的免疫重建对于预防感染和复发以及提高移植物抗肿瘤效果至关重要。B细胞在体液免疫和免疫调节中发挥着重要作用,但异体造血干细胞移植后的B细胞重建尚未得到充分研究:在这项研究中,我们分析了 252 名接受异体 HSCT 2 年的患者的 B 细胞动态,评估了各种因素对 B 细胞重建的影响及其与生存结果的相关性,以及骨髓中 B 细胞的发育阶段和外周血中的亚群:我们发现骨髓中的 B 细胞重建与外周血中的 B 细胞重建一致(p = 0.232)。男性、年龄大于 50 岁、供体年龄较大、发生慢性和急性移植物抗宿主疾病、真菌和巨细胞病毒感染都会延迟 B 细胞重建。生存分析显示,B 细胞较少的患者死亡和复发的风险较高。更重要的是,我们利用倾向得分匹配法得出了女性患者一年后B细胞重建更好的结论。同时,通过中介分析,我们提出了年龄-B 细胞-生存轴,并发现移植后第 12 个月的 B 细胞重建中介了年龄对患者生存的影响(p = 0.013)。我们还发现,年轻患者在移植后骨髓中显示出更多的未成熟B细胞(p = 0.037):我们的研究结果为优化 B 细胞重建管理、提高异体 HSCT 的疗效和安全性提供了有价值的见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
The dynamics of B-cell reconstitution post allogeneic hematopoietic stem cell transplantation: A real-world study

Background

The immune reconstitution after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is crucial for preventing infections and relapse and enhancing graft-versus-tumor effects. B cells play an important role in humoral immunity and immune regulation, but their reconstitution after allo-HSCT has not been well studied.

Methods

In this study, we analyzed the dynamics of B cells in 252 patients who underwent allo-HSCT for 2 years and assessed the impact of factors on B-cell reconstitution and their correlations with survival outcomes, as well as the development stages of B cells in the bone marrow and the subsets in the peripheral blood.

Results

We found that the B-cell reconstitution in the bone marrow was consistent with the peripheral blood (p = 0.232). B-cell reconstitution was delayed by the male gender, age >50, older donor age, the occurrence of chronic and acute graft-versus-host disease, and the infections of fungi and cytomegalovirus. The survival analysis revealed that patients with lower B cells had higher risks of death and relapse. More importantly, we used propensity score matching to obtain the conclusion that post-1-year B-cell reconstitution is better in females. Meanwhile, using mediation analysis, we proposed the age-B cells-survival axis and found that B-cell reconstitution at month 12 posttransplant mediated the effect of age on patient survival (p = 0.013). We also found that younger patients showed more immature B cells in the bone marrow after transplantation (p = 0.037).

Conclusion

Our findings provide valuable insights for optimizing the management of B-cell reconstitution and improving the efficacy and safety of allo-HSCT.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Internal Medicine
Journal of Internal Medicine 医学-医学:内科
CiteScore
22.00
自引率
0.90%
发文量
176
审稿时长
4-8 weeks
期刊介绍: JIM – The Journal of Internal Medicine, in continuous publication since 1863, is an international, peer-reviewed scientific journal. It publishes original work in clinical science, spanning from bench to bedside, encompassing a wide range of internal medicine and its subspecialties. JIM showcases original articles, reviews, brief reports, and research letters in the field of internal medicine.
期刊最新文献
Therapeutic BCG vaccine protects against long COVID: The BATTLE randomized clinical trial. Different ways of diagnosing selective glomerular hypofiltration syndromes such as shrunken pore syndrome and the associated increase in mortality. Statin-associated regulation of hepatic PNPLA3 in patients without known liver disease. Issue Information Association among major adverse cardiovascular events with immune checkpoint inhibitors: A systematic review and meta-analysis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1